The Pharma in Brief team is looking back at 2025’s most notable legal and regulatory developments in the Canadian pharmaceutical space and highlighting hot topics for 2026. To those who don’t make it to the end of the article, we’ll say it up front: all the best for 2026 & stay tuned to Pharma in Brief! 

Read the full publication